Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with extranodal NK/T-cell lymphoma (a type of cancer affecting immune cells), confirmed by tissue testing at the study centre.
- People aged between 18 and 75 years.
- People who have at least one of the following risk factors: aged 60 or older; experiencing "B symptoms" such as fever, night sweats, or unexplained weight loss; having a lower ability to carry out daily activities (confirm with trial site); having elevated levels of a blood enzyme called LDH; or having a measurable level of a virus called EBV in the blood above a certain threshold.
- People whose general physical ability to carry out daily activities falls within an accepted range on a standard medical scale (confirm with trial site).
- People whose bone marrow is producing enough blood cells, based on specific blood test results meeting minimum levels for white blood cells, platelets, and haemoglobin.
- People whose liver, kidneys, and heart are functioning adequately, based on specific blood test and heart function measurements meeting required levels.
Who may not be able to join:
- People who have aggressive NK-cell leukaemia (a related but different blood cancer).
- People whose lymphoma has spread to the central nervous system (brain and spinal cord).
- People who have experienced certain serious heart conditions in the past 6 months, including heart attack, unstable chest pain, heart failure, uncontrolled irregular heartbeat, or specific abnormalities in the heart's electrical system.
- People who have an active infection that is not under control.
- People who are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 010-69155760
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete response rate (CRR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.